openPR Logo
Press release

Granulocyte-Colony Stimulating Factor Market with Top Most Industry Players as BioCad, Celltrion Inc., Dong-A Socio Group, Pfizer Inc., Intas Pharmaceuticals Ltd, Novartis AG, Stada Arzneimittel AG and others

11-16-2018 11:46 AM CET | Health & Medicine

Press release from: Allied Market Research

Granulocyte-Colony Stimulating Factor Market

Granulocyte-Colony Stimulating Factor Market

The factors that drive the growth of the Global Granulocyte-Colony Stimulating Factor Market are increasing prevalence of cancer, growing awareness regarding the availability of various methods of cancer treatment, and rise in governmental funding towards healthcare. However, high costs of treatment modalities and stringent government regulations for approval of any new treatment options hamper the market growth.

Granulocyte-colony stimulating factor (G-CSF) is glycoprotein that stimulates the bone marrow to produce stem cells and granulocytes & release it into the bloodstream. G-CSF is produced by different tissues and its pharmacological analogs include lenograstim and filgrastim. G-CSF also stimulates proliferation, survival, differentiation, and function of mature & neutrophil precursors. G-CSF has a wide range of applications in hematology & oncology; a recombinant form of G-CSF is used with certain cancer-affected patients to reduce mortality and accelerate recovery from neutropenia after chemotherapy, thereby making way for higher-intensity treatment regimens.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/3472?utm_source=sy-Openpr

The key players of the global granulocyte-colony stimulating factor market include
• BioCad
• Celltrion Inc.
• Dong-A Socio Group
• Pfizer Inc.
• Intas Pharmaceuticals Ltd
• Novartis AG
• Stada Arzneimittel AG
• Teva Pharmaceutical Industries Ltd.
• Amgen Inc.
• Dr. Reddy's Laboratories.

The Global Granulocyte-Colony Stimulating Factor Market is segmented on the basis of type and application. Based on type, the market is categorised into capsule, tablet, and others. In terms of application, the market is divided into oncological diseases, blood disorders, growth hormone deficiencies, chronic and autoimmune disorders, and others. Regionally, the market has been analysed across North America, Europe, Asia-Pacific, and LAMEA.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/3472?utm_source=sy-Openpr

Key Benefits
• The study provides an in-depth analysis of the global granulocyte-colony stimulating factor market along with the current trends and future estimations to elucidate imminent investment pockets.
• Comprehensive analysis of the factors that drive and restrict the market growth has been provided in the report.
• Comprehensive quantitative analysis of the industry has been provided from 20162023 to assist stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps understand the trends in the types of granulocyte-colony stimulating factors globally.
• Key market players and their strategies have been provided to understand the competitive outlook of the industry.

Access Full Summery @ https://www.alliedmarketresearch.com/granulocyte-colony-stimulating-factor-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Granulocyte-Colony Stimulating Factor Market with Top Most Industry Players as BioCad, Celltrion Inc., Dong-A Socio Group, Pfizer Inc., Intas Pharmaceuticals Ltd, Novartis AG, Stada Arzneimittel AG and others here

News-ID: 1376855 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Stimulating

Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Follicle Stimulating Hormone Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for the follicle stimulating hormone (FSH) has seen robust growth in the recent past. It's projected to expand from $2.03 billion in 2024, increasing to $2.14 billion by 2025, at a
Energy Drinks Market: A Stimulating Industry
The energy drinks market has witnessed significant growth in recent years, driven by changing consumer preferences, increasing disposable incomes, and a desire for quick and convenient energy boosts. This post will delve into the market, exploring its size, share, opportunities, challenges, demand, and trends. Market Size and Share The energy drinks market is a substantial segment of the global beverage industry. While precise figures can vary depending on data sources and regional
Colony Stimulating Factors Market Boosting Immunity, Bolstering Growth: The Rise …
Colony Stimulating Factors Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Colony Stimulating Factors Market By Type (Macrophage-Colony-Stimulating Factor (M-CSF), Multiple-Colony-Stimulating Factor or Interleukin 3 (IL-3), Granulocyte-Macrophage-Colony-Stimulating Factor (GM-CSF) and Granulocyte-Colony-Stimulating Factor (G-CSF), drug (Pegfilgrastim, Tbo-filgrastim, Sargramostim and Filgrastim), Application (Aplastic Anemia, Bone Marrow Transplantation, Neutropenia, Neutropenia Associated with
Vast Applications in Bakery Industry Stimulating Revenue Growth
Global Bakery Enzymes Market Scenario Future Market Insights delivers key insights and presents a revised forecast of the global bakery enzymes market for a 10-year period from 2018 to 2028 for the report titled 'Bakery Enzymes Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028'. Revisions in the bakery enzymes market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving
Global Follicle Stimulating Hormone Sales Market Report 2017
Report Hive Market Research Released a New Research Report of 152 pages on Title " Global Follicle Stimulating Hormone Sales Market Report 2017 "with detailed Analysis, Forecast and Strategies. This report studies the Follicle Stimulating Hormone market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Follicle Stimulating
Erythropoietin Stimulating Agent Market - Global Industry Volume By 2023
GlobalErythropoietin stimulating agent market are driven by increasing number of patients suffering from anemia, anemia induced due to cancer, end stage renal disease (ESRD) and HIV treatment. In June 1989,Epoetin alfa was the first drug for EPO, manufactured by Amgen Inc. U.S FDA approved itunder the trade name “Epogen”.The global market for erythropoietin drugs are expected to grow in near future as increased cases of cancer and renal problem haveregistered.